期刊文献+

CCL18通过整合素聚集促进乳腺癌SK-3^(rd)细胞浸润和迁移

CCL18 for promoting breast cancer SK-3^(rd) cells invasion via integrin aggregation
下载PDF
导出
摘要 目的探讨整合素在CCL18促进乳腺癌SK-3rd细胞浸润和迁移过程中的作用,以阐明CCL18促进乳腺癌细胞浸润和迁移的分子机制。方法用流式细胞检测技术检测CCL18作用下乳腺癌SK-3rd细胞表面整合素的聚集;采用Western blot检测黏着斑激酶(FAK)的激活;用浸润迁移实验检测乳腺癌SK-3rd细胞的浸润迁移。用siRNA转染检测沉默SK-3rd细胞整合素β1的表达。结果 CCL18促进乳腺癌SK-3rd细胞表面整合素的聚集;从而促进整合素介导的FAK磷酸化激活。在CCL18作用下,乳腺癌SK-3rd细胞浸润和迁移的细胞数增多10倍(P<0.01);用siRNA转染检测沉默SK-3rd细胞整合素β1的表达,可以使CCL18作用下的SK-3rd细胞浸润和迁移数量明显减少。结论 CCL18通过整合素聚集可促进乳腺癌细胞浸润和迁移。 Objective To explore the role of integrin in CCL18 for promoting breast cancer SK-3 rd cells invasion and migration process to illuminate the molecular mechanism of CCL 18 for promoting breast cancer SK-3 rd cells invasion and migration process . Methods The flow cytometry was adopted to detect CCL18-induced integrin aggregation ;Western blot was used to detect the focal adhesion kinase(FAK ) activation ,the infiltrating migrationin experiment was adopted to determine the invasion and migration of SK-3rd cells and the siRNAs transfection was used to detect the expression of silence integrin β1 .Results CCL18 promoted the in-tegrinβ1 aggregation in breast cancer SK-3rd cell surface and further promoted the integrin-mediated phosphorylated activation of FAK .Under the reaction of CCL18 ,the cells number of SK-3rd cellular invasion and migration was increased by ten times (P&lt;0 .01) ,which was obviously decreased by siRNA silenced integrin β1 .Conclusion CCL18 promotes breast cancer invasion and mi-gration via integrin aggregation .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第12期1419-1421,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(81272900) 广州市属高校科技计划资助项目(08A080)
关键词 乳腺肿瘤 CCL18 肿瘤浸润 细胞运动 整合素类 breast neoplasms CCL18 tumor-infiltrating cell movement integrins
  • 相关文献

参考文献14

  • 1Raymond K, Faraldo MM,Dcugnier MA, et al. Integrins in mammary development[J]. Semin Cell Dev Biol, 2012, 23(5) :599-605.
  • 2Crowe DL, Shuler CF. Regulation of tumor cell invasion by extracellular matrix[J]. Histol Histopathol, 1999, 14 (2) 665-671.
  • 3Lechner MG, Russell SM, Bass RS, et al. Chemokines, eostimulatory molecules and fusion proteins for the im- munotherapy of solid tumors[J]. Immunotherapy, 2011,3 (11) 1317-1340.
  • 4Struyf S,Van Damme J. The role of plasma chemokines in cancer[J]. Verh K Acad Geneeskd Belg, 2007,69 (3) :149- 165.
  • 5Chen JQ, Yao YY, Gong C, et al. CCL18 from Tumor-as- sociated macrophages promotes breast cancer metastasis via PITPNM3[J]. Cancer Cell,2011,19(4) :541-555.
  • 6Bourboulia D, Stetler-Stevenson WG. Matrix metalloprotein- ases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) :Positive and negative regulators in tumor cell ad- hesion[J]. Semin Cancer Biol,2010,20(3):161-168.
  • 7Crowe DL, Shuler CF. Regulation of tumor cell invasion by extracellular matrix[J]. Histol Histopathol, 1999,14 (2) :665-671.
  • 8Ito K,Ralph SJ. Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CDS(+ ) T cells and reduced cancer cell adherence[J]. Clin Exp Metasta- sis,2012,29(6) :561-572.
  • 9Scaringi C, Minniti G, Caporello P, et al. Integrin inhibitor cilengitide for the treatment of glioblastoma:a brief over- view of current clinical results[J]. Anticancer Res, 2012, 32(10) :4213-4223.
  • 10Singh R, Lillard J W Jr, Singh S. Chemokines:key players in cancer progression and metastasis [J]- Front Biosci (Schol Ed), 2011(3) : 1569-1582.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部